These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34937906)

  • 1. Structural and functional diversity among agonist-bound states of the GLP-1 receptor.
    Cary BP; Deganutti G; Zhao P; Truong TT; Piper SJ; Liu X; Belousoff MJ; Danev R; Sexton PM; Wootten D; Gellman SH
    Nat Chem Biol; 2022 Mar; 18(3):256-263. PubMed ID: 34937906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
    Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
    Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide.
    Chang R; Zhang X; Qiao A; Dai A; Belousoff MJ; Tan Q; Shao L; Zhong L; Lin G; Liang YL; Ma L; Han S; Yang D; Danev R; Wang MW; Wootten D; Wu B; Sexton PM
    J Biol Chem; 2020 Jul; 295(28):9313-9325. PubMed ID: 32371397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor.
    Johnson RM; Zhang X; Piper SJ; Nettleton TJ; Vandekolk TH; Langmead CJ; Danev R; Sexton PM; Wootten D
    Biochem Biophys Res Commun; 2021 Nov; 578():84-90. PubMed ID: 34547628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation.
    Deganutti G; Liang YL; Zhang X; Khoshouei M; Clydesdale L; Belousoff MJ; Venugopal H; Truong TT; Glukhova A; Keller AN; Gregory KJ; Leach K; Christopoulos A; Danev R; Reynolds CA; Zhao P; Sexton PM; Wootten D
    Nat Commun; 2022 Jan; 13(1):92. PubMed ID: 35013280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R).
    Koole C; Reynolds CA; Mobarec JC; Hick C; Sexton PM; Sakmar TP
    J Biol Chem; 2017 Apr; 292(17):7131-7144. PubMed ID: 28283573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Helix or β-Turn? An Investigation into N-Terminally Constrained Analogues of Glucagon-like Peptide 1 (GLP-1) and Exendin-4.
    Oddo A; Mortensen S; Thøgersen H; De Maria L; Hennen S; McGuire JN; Kofoed J; Linderoth L; Reedtz-Runge S
    Biochemistry; 2018 Jul; 57(28):4148-4154. PubMed ID: 29877701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.
    Gómez Santiago C; Paci E; Donnelly D
    Biochem Biophys Res Commun; 2018 Mar; 498(2):359-365. PubMed ID: 29397068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
    Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
    Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
    J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
    Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
    Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein.
    Zhang Y; Sun B; Feng D; Hu H; Chu M; Qu Q; Tarrasch JT; Li S; Sun Kobilka T; Kobilka BK; Skiniotis G
    Nature; 2017 Jun; 546(7657):248-253. PubMed ID: 28538729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Responses of the GLP-1 and GLP-2 Receptors to N-Terminal Modification of a Dual Agonist.
    Gibadullin R; Cary BP; Gellman SH
    J Am Chem Soc; 2023 Jun; 145(22):12105-12114. PubMed ID: 37235770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes.
    Zhang X; Belousoff MJ; Liang YL; Danev R; Sexton PM; Wootten D
    Cell Rep; 2021 Jul; 36(2):109374. PubMed ID: 34260945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.
    Liang YL; Khoshouei M; Glukhova A; Furness SGB; Zhao P; Clydesdale L; Koole C; Truong TT; Thal DM; Lei S; Radjainia M; Danev R; Baumeister W; Wang MW; Miller LJ; Christopoulos A; Sexton PM; Wootten D
    Nature; 2018 Mar; 555(7694):121-125. PubMed ID: 29466332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
    Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
    Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
    López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
    J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of ECD conformational transition mechanism of GLP-1R by molecular dynamics simulations and Markov state model.
    Zhang J; Bai Q; Pérez-Sánchez H; Shang S; An X; Yao X
    Phys Chem Chem Phys; 2019 Apr; 21(16):8470-8481. PubMed ID: 30957116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro.
    Swedberg JE; Schroeder CI; Mitchell JM; Fairlie DP; Edmonds DJ; Griffith DA; Ruggeri RB; Derksen DR; Loria PM; Price DA; Liras S; Craik DJ
    J Biol Chem; 2016 Jul; 291(30):15778-87. PubMed ID: 27226591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
    Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R
    J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.